Resultados: 8

    Consolidated guidelines on differentiated HIV testing services

    hese guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to WHO guidelines on HTS, with a focus on new evidence, new recommendations, good practices and operational considerations that respond to the changing needs of...

    WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities

    Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. These consolidated guidelines on tuberculosis. Module 6: tuberculosis and comorbidities summarize the latest WHO recommendations on TB and key comorbidities. ...

    Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV

    Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released in 2018 ...

    WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia 

    The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leis...

    Hormonal contraceptive eligibility for women at high risk of HIV: guidance statement recommendations on contraceptive methods used by women at high risk of HIV

    The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime ...

    Hormonal contraceptive methods for women at high risk of HIV and living with HIV: 2014 guidance statement

    During 9–12 March 2014, WHO convened a meeting of the Guideline Development Group (GDG) comprising 52 individuals representing a wide range of stakeholders, for the purpose of reviewing, and where appropriate, revising its Medical eligibility criteria for contraceptive use, fourth edition (MEC) guidanc...

    Hormonal contraception and HIV: technical statement

    Following new findings from recently published epidemiological studies, the World Health Organization (WHO) convened a technical consultation regarding hormonal contraception and HIV acquisition, progression and transmission. It was recognized that this issue was likely to be of particular concern in cou...

    Inter-Agency field manual on reproductive health in humanitarian settings: 2010 revision for field review

    All people, including those living in humanitarian settings, have the right to reproductive health (RH). To exercise this right, affected populations must have an enabling environment and access to comprehensive RH information and services so they can make free and informed choices. Quality RH services m...